CD8A and cancer: Unlike conventional CD8 T cells that rely on presentation of processed peptides on the MHC-I molecule of antigen-presenting cells or cancer cells, CAR-T cells can bind to antigens directly on the target cell and relay a potent activation signal to trigger cytotoxicity against the antigen-bearing cell.